, whereas the source of low affinity binding is unknown. SkzL 
Group B streptococci (GBS)
2 cause severe diseases including sepsis, meningitis, arthritis, and endocarditis in neonates and immunecompromised patients (1, 2) . Streptococcus agalactiae serotype V is emerging as an invasive GBS pathogen with particular morbidity and mortality in neonates (3) (4) (5) , but the mechanism of GBS pathogenesis is not fully understood. Unlike Group A, C, and G streptococci, GBS does not express streptokinase (SK), a pathogenicity factor in Group A streptococcal infection (6) . Activation of the fibrinolytic system is a mechanism of bacterial pathogenesis employed by many bacteria through expression of cell-surface plasminogen (Pg) binding proteins and the secretion of Pg activators.
In this mechanism, aberrant upregulation of the fibrinolytic system increases plasmin (Pm) generation, which degrades fibrin and extracellular matrix to disseminate the bacteria through soft tissue (7) . Activation of Pg on the cell surface through Pg binding proteins, such as Pg-binding Group A streptococcal M-like protein (PAM; Group A, C, and G streptococci), glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Group A, B, and C streptococci), and α-enolase (Group A and B streptococci) results in coating of the cell surface with Pg or active Pm (8) (9) (10) (11) (12) . A recent study indicated that Pg activation on the surface of S. agalactiae occurs through the GAPDH-bound Pg complex, facilitating GBS virulence and promoting bacterial dissemination in a murine model (10) . Secreted Pg activating proteins, such as SK and staphylokinase (SAK), are not enzymes themselves but form complexes with Pg or Pm to enable proteolytic Pm generation. This proteolysis can occur locally on bacterial cell surfaces through Pg-binding proteins or systemically by the free, secreted Pg activators in the vascular system.
Although complete proteomic functional studies have not been performed, to date there are no known S. agalactiae secreted proteins with established human fibrinolytic activity. Genomic sequencing of an S. agalactiae serotype V clinical isolate (2603 V/R) revealed 2,175 predicted genes (13) , including NP_688136.1, which corresponds to a novel protein of unknown function, subsequently named skizzle (SkzL). SkzL has 22% sequence identity to SK from Streptococcus equisimilis and pyogenes, 33% to SAK from Staphylococcus aureus and 24% to PauB, a bovine Pg activator from Streptococcus uberis (14) . In studies of genomic sequence diversity, SkzL (protein unnamed, gene name sk1A2) had weak similarity to SAK and SK (4) . SAK, SK, and PauB facilitate the conversion of Pg into Pm, albeit through different mechanisms.
Native [Glu] Pg, the form circulating in blood, consists of an NH 2 -terminal PAN (Pg/apple/nematode) module, 5 kringle domains, and a serine proteinase catalytic domain. Kringles 1, 4, and 5 contain lysine-binding sites (LBS) with moderate to low affinity for L-lysine and higher affinity for the lysine analog, 6-aminohexanoic acid (6-AHA) (15) (16) (17) (18) (19) (20) . Following cleavage by Pm, the NH 2 -terminal 77-residue PAN module of [Glu] Pg is released to yield [Lys]Pg (18) . As a result of the NH 2 -terminal PAN module interaction with kringle 5, [Glu] Pg is stabilized in the compact α-conformation by physiological concentrations of chloride ion (21, 22) . The α-conformation of [Glu] Pg, however, is in equilibrium with a low concentration of a partially extended, β-conformation governed by the chloride ion concentration (17, (22) (23) (24) (25) . Lacking the PAN module, [Lys] Pg adopts the β-conformation in the absence or presence of chloride ion (22, 26) . Upon low affinity binding of lysine analogs, such as 6-AHA to kringles 4 and 5, both [Glu] Pg and [Lys]Pg assume the fully extended γ-conformation (22, 23, (26) (27) (28) (29) (30) (31) (32) .
Proteolytic Pg activation occurs through cleavage of the Arg 561 -Val 562 peptide bond in the catalytic domain to form Pm. SK activates Pg through a conformational, non-proteolytic molecular sexuality mechanism (33) (34) (35) (36) (37) (38) (43) (44) (45) . PauB and its homolog, PauA appear to follow a mechanism similar to SK, including formation of a non-proteolytically activated Pg complex, followed by proteolysis of substrate molecules of Pg, but are specific for activation of bovine Pg (46) (47) (48) (49) (50) .
Human Pg is proteolytically activated endogenously by either of two activators, urokinase and tissue-type plasminogen activator (tPA).
High molecular weight single-chain urokinase (uPA) contains a catalytic domain in the NH 2 -terminal region and an epidermal growth factor domain and one kringle domain in the COOH-terminal region (51, 52 (56) .
One structural difference between tPA and uPA is the presence of a second kringle domain in tPA containing an LBS with high affinity for lysine, 6-AHA, and fibrin fragments (57, 58) .
The modest sequence identity between SkzL and SK includes conservation of the NH 2 (39) (40) (41) 62) . Native Pm activity was calculated based on known parameters for D-Val-Leu-Lys-pnitroanalide (VLK-pNA) hydrolysis (41) . Human high molecular weight uPA (Calbiochem) was reconstituted in ultra-pure water (yielding a solution containing 150 mM Cl -contributed by NaCl and Tris-Cl). Protein concentration of uPA and sctPA were determined by bicinchoninic acid protein assay (Pierce).
sctPA (Molecular Innovations) was stored in 0.5 M HEPES, 0.5 M NaCl, pH 7.4 buffer to ensure solubility and was limited to one freeze-thaw cycle to maintain stable activity.
The gene for SkzL (NP_688136.1) was cloned from S. agalactiae 2603 V/R genomic DNA (ATCC) into a modified pET30b(+) (Novagen) vector (59) 
RESULTS

constants.
Plasminogen Activation Kinetics-The kinetics of activation of 100 nM [Glu]Pg or 100 nM [Lys]Pg by uPA (0.32 or 0.11 nM, respectively) or sctPA (3 nM) as a function of SkzL concentration were performed by continuous measurement of hydrolysis of 200 µM VLK-pNA at 405 nm and 25 °C, as previously described (35, 42) . Assays were performed in chloride containing buffer (100 mM HEPES, 100 mM NaCl, 1 mM EDTA, 1 mg/ml PEG 8,000, pH 7.4) or no chloride buffer (100 mM HEPES, 100 mM sodium acetate, 1 mM EDTA, 1 mg/ml PEG 8,000, pH 7.4) using PEG 20,000-coated polystyrene cuvettes. In assays containing SkzL, uPA or sctPA and SkzL diluted in buffer were preincubated in the cuvette at 25 °C for 10 min prior to addition of Pg and substrate. Progress curves at varying SkzL concentrations were fit by the parabolic rate equation and truncated to include only data linear when plotted as absorbance against t substrate consumption.
Plasma Clot Lysis-Plasma clot lysis was measured by incubation of 160 µL normal human plasma at 37 °C with final concentrations of 6 nM thrombin, 10 mM CaCl 2 , and 7 nM uPA or 1.5 nM sctPA, in a final volume of 200 µL. All proteins were diluted in 50 mM HEPES, 125 mM NaCl, pH 7.4 prior to addition. Increasing concentrations of SkzL were preincubated for 10 min at 37 °C with 10 mM CaCl 2 and either uPA or sctPA in the above buffer prior to addition of thrombin and plasma to initiate the assay. Turbidity was measured at 650 nm in a microtiter plate-reader. Results are reported as time to halfclot lysis as a function of SkzL concentration, and analyzed by Eq. 1, where [P] o was 1.6 µM, representing the dilution-cor µM (67) . . During the expression and purification of monomeric SkzL, trace amounts of a disulfidebonded dimeric form was generated. Dimeric and monomeric SkzL were separated by anion exchange chromatography as described in "Experimental Procedures" to yield pure monomeric SkzL and a 1:1 mixture of monomeric and dimeric SkzL ( Fig. 2A, lanes 2, 3 and 6, 7) . Results of cysteine-to-serine mutagenesis studies indicated that Cys 120 was buried within the protein and that Cys 393 and Cys 401 occurred partially as free thiols and partially as an internal disulfide bond (Table S1 ). The results also indicated that trace levels of disulfide-mediated dimeric SkzL may occur through Cys 393 or Cys
401
. These results were confirmed by mass spectrometry analysis of a thiol-specific 5-fluorescein-labeled analog of SkzL monomer ( Fig. 2A, lanes 1 and 5) Secretion of SkzL by S. agalactiae-As shown by western blotting with a polyclonal anti-SkzL antibody, SkzL was secreted in monomeric form by S. agalactiae serotype V in all growth phases (Fig. 2B) . The subsequent studies were restricted to monomeric SkzL as this was the secreted and putative physiological form of the protein. Mass spectrometry of triplicate bacterial supernatant samples confirmed that SkzL was present in both the mid-logarithmic and stationary phases of S. agalactiae growth (Table S2) . Nineteen proteins were consistently observed in the S. agalactiae secretome during at least one growth phase, including the Pg-binding proteins, α-enolase and GAPDH. All peptides identified distinct proteins with no cross-identifications. NP_687847.1, a putative staphylocoagulase homolog, was also identified in the proteomic analysis (71) . Fig. 5A and B ; Table 2 Table 2 ). The low affinity interactions were not well determined, with dissociation constants of ~18 and ~20 µM, respectively, and appeared to be due to a decrease in anisotropy. When vertically polarized light was used for excitation and emission polarizers were set to the magic angle to eliminate anisotropy, only the high affinity SkzL interaction was observed, with K D 's for labeled [Glu]Pg, [Lys]Pg and Pm indistinguishable from those obtained for the bimodal titrations ( Fig. 5D and F; Fig  5C and E) and magic angle (Fig. 5D and F) conditions gave weak K D 's of 3-12 µM ( Table 2) . The low affinity binding of SkzLΔK415 was eliminated in the presence of 6-AHA, consistent with more than one LBS-dependent interaction between SkzL and Pg/Pm. (Table 3) . SkzL had no effect on the rate of hydrolysis of chromogenic substrates with Lys at the P1 3 position (D-VLK-pNA, pyro-Glu-PheLys-pNA, and D-Val-Phe-Lys-pNA). However, similar effects on k cat were seen with other substrates with Arg at the P1 position (D-Ile-ProArg-pNA and D-Val-Leu-Arg-pNA) (results not shown). Titration with SkzL at 200 µM pyro-EPR-pNA showed two distinct LBS-dependent binding interactions between SkzL and native Pm, with apparent dissociation constants of 170 ± 140 nM and ~9 µM, where the latter value was poorly determined (Fig. 6) . Titration with SkzL∆K415 demonstrated a loss of the high affinity interaction and an LBS-dependent low affinity interaction with a K D of 3.8 ± 1.2 µM (Fig. 6) .
Binding of Pg and FFR-Pm to [5F]-SkzL-
LBS-mediated Binding of SkzL to Active Pm-
To detect any changes in Pm chromogenic substrate kinetics on binding to SkzL, assays were performed by continuous measurement of the initial rates of pyro-EPR-pNA hydrolysis by Pm as a function of SkzL concentration. Comparison of the Michaelis-Menten kinetic parameters in the absence and presence of 1 or 5 µM SkzL, showed a 1.7-fold decrease in k cat compared to free Pm, no significant change in K m , and a 2-fold decrease in k cat /K m
Effect of SkzL on Plasminogen
Activation by uPA-Chromogenic substrate kinetic assays of Pm formation were performed to determine the effect of SkzL on activation of [Glu]Pg and [Lys]Pg by uPA. To investigate the possible effects of SkzL on Pg conformation, assays were done in the absence and presence of 10 mM 6-AHA and in low chloride ion buffer, with the uPA preparation as the only source of Cl -(0.45 mM in the reactions) and in buffer containing 100 mM Cl -. In the presence of 100 mM Cl -, saturating SkzL concentrations resulted in a ~2-fold decreased rate of [Lys]Pg activation with minimum rates of Pm generation equivalent to those in the presence of 10 mM 6-AHA (Fig. 7A) (Table 2 ). This very large difference suggested that a different mechanism was involved for sctPA.
SkzL Enhances uPA-and sctPA-mediated Plasma
Clot Lysis -Plasma clot lysis experiments were performed to assess the role of SkzL as an effector of uPA-and sctPA-mediated Pg activation in a physiological model system of fibrinolysis. Human plasma and 6 nM human thrombin were reacted with a preincubated mixture of either 7 nM uPA or 1.5 nM sctPA and increasing concentrations of SkzL. The results were expressed as time to half-clot lysis as a function of SkzL concentration (72) . SkzL enhanced clot lysis by uPA and sctPA, decreasing the time to half-clot lysis by ~2-fold (Fig. 9) . No clot lysis was observed in the absence of uPA or sctPA.
DISCUSSION
SkzL from S. agalactiae has modest homology to the bacterial Pg activators, SAK, SK, and PauB, and is secreted as the monomeric, 47,400-Da form by S. agalactiae throughout its growth cycle. Nineteen proteins were identified in the S. agalactiae secretome, including α-enolase and GAPDH, which are known to bind Pg. In contrast to SK, SAK, and PauB, SkzL ) and a motif in SAK (Lys 97 -Lys-Glu-Glu 100 ), certain residues of which are implicated in mediating LBS-dependent Pg substrate interactions with SK•Pg* and SAK•Pm catalytic complexes (42, 73) . The similar motif in SkzL may be responsible for the low affinity interaction. Future mutagenesis studies may be used to establish the SkzL residues involved in mediating this weak interaction.
Pg can adopt three distinct conformations that affect its potential for activation by tPA and uPA. The compact nature of the α-conformation of [Glu]Pg, stabilized by physiological chloride concentrations, makes it a poor substrate for uPA, tPA, and SK, compared with the partially extended, chloride-independent β-conformation of [Lys]Pg (17, (22) (23) (24) (25) 49, 66) . Upon occupation of [Glu]Pg and [Lys]Pg kringles 1, 4 and 5 by 6-AHA, the transition to the fully extended γ-conformation also results in enhanced activation by uPA (21, (23) (24) (25) .
Due to the highly LBS-dependent nature of SkzL binding to Pg, it was hypothesized that SkzL-Pg binding could mimic the conformational change induced by 6-AHA binding, resulting in the extension of [Glu]Pg and [Lys]Pg from the α-and β-conformations, respectively, to the γ-conformation. Activation of [Lys]Pg by uPA, however, was inhibited by SkzL to a rate equivalent to that in the presence of either 10 mM 6-AHA or saturating SkzL. In these experiments, the apparent dissociation constants for SkzL-[Lys]Pg binding were ~4-fold weaker than the native affinity determined by competitive binding. This discrepancy may be due to the inability to discern both the high and low affinity interactions between SkzL and Moreover, the mechanism of SkzL-enhanced [Glu]Pg activation by uPA is shown for the first time to be caused by SkzL-mediated transformation of [Glu]Pg from the activation-resistant, α-conformation to the more rapidly activated, γ-conformation.
This mechanism and a hypothetical interpretation of the results of the binding studies for [Lys] Pg and Pm are presented in Fig. 10 . In this scheme, [Glu]Pg in the α-conformation is in unfavorable equilibrium (Reaction 1) with the β-conformation, which is governed by the Cl -concentration (17, (23) (24) (25) . SkzL binds preferentially to the β-conformation, mediated by Lys 415 binding to kringle 4, and accompanied by transition of [Glu] Pg to the γ-conformation (Reactions 1 and 2) , which is more susceptible to activation by uPA (Reaction 3). The proposal of kringle 4 as the Lys 415 binding site is based on the preference of kringle 4 for COOH-terminal Lys residues (26, 31, 74) , and preferential binding of SkzL to the [Glu]Pg β-conformation is supported by evidence that kringle 4 is masked in the α-conformation (26, (75) (76) (77) . LBS-dependent monoclonal antibody binding specific for kringle 4 has been hypothesized to induce an activationenhancing conformational change (23, 26, 30) distinct from the α-to β-conformational change caused by disruption of the PAN module-kringle 5 interaction (27, 78) , suggesting a role for kringle 4 in modulating the β-to γ-conformational change (23, 30, 32 , such an interaction with sctPA may result in higher order complex formation, which will require further experimentation to evaluate.
The present studies show that SkzL is a novel protein that is modestly homologous to SK, secreted from S. agalactiae, and acts as a cofactor of sctPA and uPA in accelerating Pg activation. Recent studies have established that an interaction of cell surface-bound GAPDH with Pg contributes to the virulence of GBS invasive infection in an in vivo murine model (10) . The present studies reveal SkzL as an additional component in the interactions between GBS and the proteins of the human fibrinolytic system. As a secreted protein, SkzL may play a role as a Pg-binding protein different from the cell surface-bound Pg-binding proteins, α-enolase and GAPDH, in the context of GBS infection, or it could act in cooperation with these proteins through as yet, unknown interactions. SkzL has high affinity for Pg and Pm relative to the plasma Pg concentration of 2 µM (67), and binds through a strictly LBS-dependent mechanism involving the kringle domains of Pg and Pm. SkzL is a novel effector of uPA-mediated [Glu]Pg activation through a LBS-dependent mechanism similar to 6-AHA (22, 29) . The studies suggest that the role of SkzL as an effector of Pg activation by uPA is specific for the circulating form of Pg in blood, [Glu]Pg. SkzL also enhances sctPA-mediated [Glu]Pg and [Lys]Pg activation through a different mechanism that will be examined in further studies. The finding that SkzL enhances clot lysis by both physiological Pg activators in plasma provides strong support for a role of SkzL in the interaction of GBS with the human fibrinolytic system. SkzL has the potential to be a new virulence factor in life-threatening S. agalactiae infections of neonates and immunecompromised individuals. Table  1 . Experiments were performed and the data analyzed as described in "Experimental Procedures". Table 4 . Experiments were performed and the data analyzed as described in "Experimental Procedures". . Following dilution of all proteins in 50 mM HEPES, 125 mM NaCl, pH 7.4, SkzL was preincubated with 10 mM CaCl 2 , 7 nM uPA or 1.5 nM sctPA for 10 min at 37 °C prior to addition of 6 nM thrombin and 160 µL of plasma (200 µL assay volume). Clot lysis was measured by turbidity as described in "Experimental Procedures". Analysis of clot lysis by uPA and sctPA gave apparent K D 's of 1.9 ± 0.9 µM and 2.5 ± 2.5 µM, respectively. [5F]-SkzL FFR-Pm SkzL∆K415 9 ± 3 1500 ± 600 -34 ± 1 
